Concepedia

M. Timothy Cooke

MT

Statistics

Publications

3

Citations

290

H-Index

3

Active since

2017

Affiliations

NovaDigm Therapeutics (United States)(Current)

M. Timothy Cooke is an author at NovaDigm Therapeutics (United States) specializing in vaccine development, vaccination, and vaccine safety.

Top concepts

MedicineImmunologyVaccinationVaccine SafetyInfection ControlVaccine DevelopmentVaccine Surveillance

Publications per year

2017–2021

3

Publications

3

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

John E. Edwards, Michael M. Schwartz, Clint S. Schmidt et al. · Clinical Infectious Diseases · 2018 · 192 citations · Full text

<i>In Vitro</i> and <i>In Vivo</i> Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection

Thomas Colley, Alexandre Alanio, Steven L. Kelly et al. · Antimicrobial Agents and Chemotherapy · 2017 · 82 citations · Full text

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees

Eugene V. Millar, Jason W. Bennett, Burc Barin et al. · Vaccine · 2021 · 16 citations · Full text

Vaccination, Vaccine Safety, Staphylococcus Aureus Colonization +9

1–3 of 3